Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.03 | 2.05 | 0.81 | 0.10 |
| FCF Yield | 8.83% | 3.69% | 5.29% | 4.13% |
| EV / EBITDA | 9.38 | 20.78 | 17.37 | 15.73 |
| Quality | ||||
| ROIC | 5.22% | 4.36% | 4.24% | 6.92% |
| Gross Margin | 23.26% | 23.37% | 23.05% | 22.03% |
| Cash Conversion Ratio | 1.60 | 1.92 | 2.21 | 2.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.89% | 3.69% | 0.19% | 20.50% |
| Free Cash Flow Growth | -15.23% | 4.78% | 47.53% | 2.27% |
| Safety | ||||
| Net Debt / EBITDA | 3.98 | 4.53 | 5.09 | 4.86 |
| Interest Coverage | 4.99 | 4.92 | 3.23 | 2.50 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 100.88 | 96.94 | 98.95 | 88.08 |